Home › Targets › menin
menin (3 companies · 13 programs)
Companies with an active program directed at menin.
- KOMZIFTI — Acute Myeloid Leukemia Approved
- KOMZIFTI — Pediatric Acute Leukemia Phase 1
- KOMZIFTI — Gastrointestinal Stromal Tumor Phase 1
- KOMZIFTI — Acute Lymphoblastic Leukemia Phase 1
- KO-7246 Preclinical
- KO-7246 — Type 1 Diabetes Preclinical
- KO-7246 — Type 2 Diabetes Preclinical
- Revuforj — Relapsed/Refractory Acute Leukemia with KMT2A Translocation Approved
- Revuforj — Relapsed/Refractory Acute Myeloid Leukemia with NPM1 Mutation Approved
- Revuforj — Myelofibrosis Preclinical
- SNDX-62122 — Myelofibrosis Preclinical
- icovamenib — Type 2 Diabetes Phase 2
- icovamenib — Obesity Preclinical
